# Conditioned Pharmacotherapeutic Effects in Hypertension

> **NCT02056626** · PHASE4 · COMPLETED · sponsor: **University of Rochester** · enrollment: 44 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** carvedilol

## Key facts

- **NCT ID:** NCT02056626
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2018-11-30
- **Final completion:** 2018-12-31
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2019-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02056626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02056626, "Conditioned Pharmacotherapeutic Effects in Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02056626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*